Amphista Therapeutics

‘Katja and her team have expertly supported us at Amphista as we’ve developed our communications strategy. Her insights in executing our recent communications of our fundraise, even in these challenging times resulted in extensive and highly relevant media coverage as well as an impressive number of LinkedIn hits. This has resulted in opening valuable avenues for progressing our business development, recruitment and funding objectives.’

Nicki Thompson
CEO of Amphista

Objectives

To tell Amphista’s story to potential partners and investors and differentiate its technology in the protein degradation space
Announce Amphista’s USD 7.5m Series A financing, leading to raised awareness with potential partners, investors and employees, of the company’s work to advance targeted protein degradation assets in cancer

Strategy

Acted as strategic communications advisor
Identified key messages to differentiate Amphista’s platform in the protein degradation space
Drafting press releases and set up media briefings under embargo
Co-ordinated communications activities with third parties including investors
Engaging with the media to tell Amphista’s story

Results

Secured significant coverage in top tier global trade media
Financing news directly led to recruitment of new Chief Scientific Officer